Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

NACompletedINTERVENTIONAL
Enrollment

106,881

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

May 23, 2018

Study Completion Date

June 21, 2018

Conditions
Healthy
Interventions
DEVICE

Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay

For all donor specimens with investigational Alinity s HBsAg and Alinity s HBsAg Confirmatory results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

DEVICE

Alinity s HTLV I/II Assay

For all donor specimens with investigational Alinity s HTLV I/II results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

DEVICE

Alinity s Anti-HCV Assay

For all donor specimens with investigational Alinity s Anti-HCV results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

DEVICE

Alinity s HIV Ag/Ab Combo Assay

For all donor specimens with investigational Alinity s HIV Ag/Ab Combo results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

DEVICE

Alinity s Anti-HBc Assay

For all donor specimens with investigational Alinity s Anti-HBc results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

DEVICE

Alinity s Chagas Assay

For all donor specimens with investigational Alinity s Chagas results that are discordant with final status after supplemental testing, an attempt will be made to obtain a follow-up whole blood specimen approximately 4 to 6 weeks after initial donation for further analysis.

Trial Locations (5)

33431

Biotest Pharmaceuticals Corporation, Boca Raton

37932

CSL Plasma Inc., Knoxville

63108

American Red Cross National Testing Laboratory, St Louis

78201

QualTex Laboratories, San Antonio

98057

Bloodworks Northwest, Renton

All Listed Sponsors
lead

Abbott Diagnostics Division

INDUSTRY

NCT03285295 - Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol | Biotech Hunter | Biotech Hunter